Kristen Pierce

Insider Reports History

Entity
Individual
Location
Cero Therapeutics Holdings, Inc., 201 Haskins Way, Suite 230, South San Francisco, CA
Signature
/s/ Chris Erhlich, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen Pierce:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CERO THERAPEUTICS HOLDINGS, INC. Chief Development Officer Stock Option (Right to Buy) 200K Oct 1, 2024 Direct

Insider Reports Filed by Kristen Pierce

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERO CERO THERAPEUTICS HOLDINGS, INC. Oct 1, 2024 1 $0 4 Oct 2, 2024 Chief Development Officer
CERO CERO THERAPEUTICS HOLDINGS, INC. Oct 1, 2024 0 $0 3 Oct 2, 2024 Chief Development Officer